Kerstin Stemmer
Overview
Explore the profile of Kerstin Stemmer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
59
Citations
1992
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lark D, Stemmer K, Ying W, Crewe C
Nat Metab
. 2024 Aug;
6(10):1839-1841.
PMID: 39187615
No abstract available.
2.
Krause C, Britsemmer J, Bernecker M, Molenaar A, Taege N, Lopez-Alcantara N, et al.
Elife
. 2024 Jul;
12.
PMID: 39037913
Background: The development of obesity-associated comorbidities such as type 2 diabetes (T2D) and hepatic steatosis has been linked to selected microRNAs in individual studies; however, an unbiased genome-wide approach to...
3.
Glunk V, Laber S, Sinnott-Armstrong N, Sobreira D, Strobel S, Batista T, et al.
Nat Metab
. 2023 May;
5(5):861-879.
PMID: 37253881
Recent large-scale genomic association studies found evidence for a genetic link between increased risk of type 2 diabetes and decreased risk for adiposity-related traits, reminiscent of metabolically obese normal weight...
4.
Kulaj K, Harger A, Bauer M, Caliskan O, Gupta T, Chiang D, et al.
Nat Commun
. 2023 Feb;
14(1):709.
PMID: 36759608
Adipocyte-derived extracellular vesicles (AdEVs) are membranous nanoparticles that convey communication from adipose tissue to other organs. Here, to delineate their role as messengers with glucoregulatory nature, we paired fluorescence AdEV-tracing...
5.
Quarta C, Stemmer K, Novikoff A, Yang B, Klingelhuber F, Harger A, et al.
Nat Metab
. 2022 Aug;
4(8):1071-1083.
PMID: 35995995
Dual agonists activating the peroxisome proliferator-activated receptors alpha and gamma (PPARɑ/ɣ) have beneficial effects on glucose and lipid metabolism in patients with type 2 diabetes, but their development was discontinued...
6.
Abuhattum S, Kotzbeck P, Schlussler R, Harger A, Ariza de Schellenberger A, Kim K, et al.
Sci Rep
. 2022 Jun;
12(1):10325.
PMID: 35725987
Adipose tissue expansion involves both differentiation of new precursors and size increase of mature adipocytes. While the two processes are well balanced in healthy tissues, obesity and diabetes type II...
7.
Evers S, Shao Y, Ramakrishnan S, Shin J, Bozadjieva-Kramer N, Irmler M, et al.
Cell Rep
. 2022 Jan;
38(3):110270.
PMID: 35045308
Gastric bypass and vertical sleeve gastrectomy (VSG) remain the most potent and durable treatments for obesity and type 2 diabetes but are also associated with iron deficiency. The transcription factor...
8.
Aliluev A, Tritschler S, Sterr M, Oppenlander L, Hinterdobler J, Greisle T, et al.
Nat Metab
. 2021 Sep;
3(9):1202-1216.
PMID: 34552271
Excess nutrient uptake and altered hormone secretion in the gut contribute to a systemic energy imbalance, which causes obesity and an increased risk of type 2 diabetes and colorectal cancer....
9.
Oppenlander L, Palit S, Stemmer K, Greisle T, Sterr M, Salinno C, et al.
Mol Metab
. 2021 Sep;
54:101330.
PMID: 34500108
Objective: The effectiveness of bariatric surgery in restoring β-cell function has been described in type-2 diabetes (T2D) patients and animal models for years, whereas the mechanistic underpinnings are largely unknown....
10.
Zhang Q, Delessa C, Augustin R, Bakhti M, Collden G, Drucker D, et al.
Cell Metab
. 2021 Feb;
33(4):833-844.e5.
PMID: 33571454
Uncertainty exists as to whether the glucose-dependent insulinotropic polypeptide receptor (GIPR) should be activated or inhibited for the treatment of obesity. Gipr was recently demonstrated in hypothalamic feeding centers, but...